Accelerate your study with our range of unique scientific techniques
Did you know we provide an array of scientific solutions for our sponsors? One of these bespoke and highly interesting offerings is Human...
MAC Clinical Research now incorporated in Australia
To continue to meet the research needs of our clients and their patients across the globe, MAC Clinical Research has arrived in...
MAC enters partnership with Kariya Pharmaceuticals
MAC enters partnership with Kariya Pharmaceuticals with the commencement of Phase I trial for Parkinson’s drug. We are excited to partner...
A proud year: Looking back on 2022
As we approach the end of the year, it’s only natural to reflect on the previous 12 months, whether from a personal or professional...
Keeping the patient at the heart of our research
Keeping the patient at the heart of our research: My take-homes from speaking at the C3 Summit discussing inclusivity and diversity in...
MAC Clinical Research appointed to conduct psychedelic trial for Major Depressive Disorder (MDD)
SmallPharma, a biotechnology company focused on short-acting psychedelic-assisted therapies for mental health conditions has enlisted MAC...
Continuing our legacy for more than 30 years with our free memory clinics
At MAC, we have a proud history of establishing one of the UK’s first ever memory clinics back in 1988. Whilst we now operate as a...
MAC receives recognition by BritishAmerican Business (BAB) as part of Transatlantic Growth Campaign
The Transatlantic Growth campaign (TAG) is an annual campaign that highlights and celebrates businesses that demonstrate growth and...
MAC Opens US Office/Study Site
To continue to meet the research needs of our clients and their patients across the globe, MAC Clinical Research has arrived in the...
MAC Clinical Research has been appointed to accelerate timeline of Phase I/IIa clinical trial
Small Pharma Inc., a neuro-pharmaceutical company focused on psychedelic-assisted therapy, have announced the expansion of its phase...
